Tensions rise as Pacquiao camp ups ante over drugs | Inquirer Sports

Tensions rise as Pacquiao camp ups ante over drugs

/ 07:04 AM March 21, 2015

Manny Pacquiao, Bob Arum, Leonard Ellerbe

Manny Pacquiao. AP FILE PHOTO

LOS ANGELES—Tensions appeared to be rising around the long-awaited welterweight world title fight between Manny Pacquiao and Floyd Mayweather Jr., with the fighters’ camps reportedly at odds over a proposed doping penalty.

Pacquiao adviser Michael Koncz told the Los Angeles Times on Thursday that he was “a little puzzled and dismayed” that Mayweather wouldn’t agree to the $5-million penalty Pacquiao had proposed should either fighter test positive for a banned drug.

Article continues after this advertisement

Mayweather Promotions chief executive Leonard Ellerbe, however, told the newspaper that the drug testing protocol for the May 2 fight in Las Vegas had been “rigorously negotiated” by Pacquiao promoters Top Rank.

FEATURED STORIES

In comments to ESPN.com, Ellerbe called Koncz an “idiot.” “If this moron didn’t convey his fighter’s wishes when the negotiation was going on that’s their problem,” Ellerbe said. “This is a lame-ass attempt to generate publicity.” Drug testing was an issue in attempts to put a Pacquiao-Mayweather fight together in late 2009 and early 2010.

Mayweather wanted random Olympic-style blood and urine testing, but Pacquiao objected to some of the protocols and the deal disintegrated.

Article continues after this advertisement

Long and winding road Mayweather later accused the Filipino ring icon of using performance-enhancing drugs, a charge which Pacquiao denied.

Article continues after this advertisement

Pacquiao sued Mayweather over the accusation and the two settled out of court.

Article continues after this advertisement

Drug-testing differences have been just part of the long and winding road to the May 2 matchup between the two fighters widely considered the best pound-for-pound fighters of their generation.

Working together

Article continues after this advertisement

The bout has required rival telecasters Showtime and HBO to work together to produce a fight considered a lock to break all records for pay-per-view viewers and revenue.

Pacquiao, a two-term congressman from Sarangani province, is 57-5 with two draws and 38 knockouts while Mayweather is 47-0 with 26 knockouts.

Money-saving ploy?

Last week, the US Anti-Doping Agency (Usada) said both fighters had agreed to undergo Olympic-style random drug testing prior to the bout.

Mayweather has submitted to Usada testing for all of his bouts since 2010.

Both fighters must provide Usada with their whereabouts and make themselves available for blood and urine tests for drugs including human growth hormone and the blood-boosting erythropoietin.

Extra insurance

Pacquiao first suggested the reciprocal fine for a failed drug test as extra insurance that a doping issue wouldn’t scupper the fight that fans worldwide have clamored for.

But Ellerbe charged the arrangement was an attempt to “put a $5 million price tag if Manny tested positive.”

“It will cost Manny a lot more than some $5 million if he comes up positive,” Ellerbe said. AFP

RELATED STORIES

Pacquiao undergoes random blood, urine testing

Pacquiao and the Pinoy fear of blood extraction

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more updates on Pacquiao-Mayweather “Fight of the Century,” visit The Pacquiao Files.

TAGS: drug testing, Floyd Mayweather Jr., Manny Pacquaio, Michael Koncz, Pacquiao, Pacquiao vs Mayweather US, Top Rank

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.